Pages that link to "Q24245418"
Jump to navigation
Jump to search
The following pages link to Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24245418):
Displaying 50 items.
- Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24195000) (← links)
- Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24197981) (← links)
- Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24200513) (← links)
- Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24200642) (← links)
- Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants (Q24235360) (← links)
- Folic acid supplementation for the prevention of anaemia in preterm neonates (Q24236328) (← links)
- Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24245091) (← links)
- Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q24245263) (← links)
- Recent trends in erythropoietin-mediated neuroprotection (Q24649547) (← links)
- Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity (Q26772889) (← links)
- Darbepoetin Administration in Term and Preterm Neonates (Q28085116) (← links)
- Neuroprotective potential of erythropoietin in neonates; design of a randomized trial (Q31071784) (← links)
- Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial (Q33382457) (← links)
- Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants (Q33574935) (← links)
- Treatment and Prevention of Neonatal Anemia (Q33704390) (← links)
- Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants (Q34508617) (← links)
- Effects of transfusions in extremely low birth weight infants: a retrospective study (Q34573299) (← links)
- New-onset maternal gestational hypertension and risk of retinopathy of prematurity (Q34735110) (← links)
- Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy. (Q35079550) (← links)
- Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration (Q35225120) (← links)
- Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants (Q35565920) (← links)
- The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (Q35683857) (← links)
- Epo and other hematopoietic factors (Q36059793) (← links)
- Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics (Q36277628) (← links)
- A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia (Q36536434) (← links)
- Multidose optimization simulation of erythropoietin treatment in preterm infants (Q36587146) (← links)
- Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks (Q36652800) (← links)
- A randomized, masked study of weekly erythropoietin dosing in preterm infants (Q36687686) (← links)
- Vascular endothelial growth factor in eye disease (Q36929380) (← links)
- A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants (Q36952268) (← links)
- When to transfuse preterm babies. (Q37148196) (← links)
- Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple (Q37375095) (← links)
- Effects of Sterculia setigera Del. Stem Bark Extract on Hematological and Biochemical Parameters of Wistar Rats (Q37496571) (← links)
- Medical decision support using machine learning for early detection of late-onset neonatal sepsis (Q37598945) (← links)
- Erythropoietin for infants with hypoxic-ischemic encephalopathy (Q37678885) (← links)
- Recent advances toward defining the benefits and risks of erythrocyte transfusions in neonates (Q38023134) (← links)
- Mechanisms and management of retinopathy of prematurity (Q38069895) (← links)
- Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates (Q38188856) (← links)
- Exploring the use of expanded erythroid cells for autologous transfusion for anemia of prematurity (Q39446695) (← links)
- Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on streptozotocin-induced diabetic Wistar rats (Q39508769) (← links)
- Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates (Q42949621) (← links)
- Inhibition of carbohydrate and lipid digestive enzymes activities by Zygophyllum album extracts: effect on blood and pancreas inflammatory biomarkers in alloxan-induced diabetic rats. (Q44012842) (← links)
- Risk factors and prevention of retinopathy of prematurity (Q46208242) (← links)
- Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants (Q46213274) (← links)
- Early erythropoiesis-stimulating agents in preterm or low birth weight infants (Q47176323) (← links)
- Promoting neuroregeneration after perinatal arterial ischemic stroke: Neurotrophic factors and mesenchymal stem cells (Q48096160) (← links)
- Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity? (Q85204911) (← links)
- Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants (Q89672645) (← links)
- Early erythropoiesis-stimulating agents in preterm or low birth weight infants (Q89672648) (← links)
- Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research (Q89879457) (← links)